Citi raises Royalty Pharma stock price target to $42 on CF and Tremfya growth

4 months ago 20
Read Entire Article
  1. Homepage
  2. Finance
  3. Citi raises Royalty Pharma stock price target to $42 on CF and Tremfya growth

Related

Salesforce.com stock price target raised to $235 from $225 at DA Davidson

Salesforce.com stock price target raised to $235 from $225 a...

2 minutes ago 0
US weekly jobless claims drop to lowest level in more than three years

US weekly jobless claims drop to lowest level in more than t...

2 minutes ago 0
Five Below stock rating reiterated by KeyBanc amid merchandise-led turnaround

Five Below stock rating reiterated by KeyBanc amid merchandi...

2 minutes ago 0

Trending

1. chad powers glen powell
2. dc pipe bomber
3. economic calendar
4. taylor lewan
5. gma deals and steals today
6. michael dell net worth
7. winter weather warnings
8. sigourney weaver
9. rosalia tour
10. pantone color of the year 2026

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

10 months ago 623
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

8 months ago 492
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

9 months ago 354
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

11 months ago 311
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

9 months ago 311
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved